NOPIFY

Serial Number 98101402
606

Registration Progress

Application Filed
Jul 25, 2023
Under Examination
Jul 2, 2024
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NOPIFY
Previous Owner: Orexo AB
Classes: 005

Trademark Image

NOPIFY

Basic Information

Serial Number
98101402
Filing Date
July 25, 2023
Published for Opposition
May 7, 2024
Abandonment Date
February 3, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 3, 2025
Classes
005

Rights Holder

Orexo AB

03
Address
Virdings allé 32 A
Uppsala SE-75450
SE

Ownership History

Orexo AB

Original Applicant
03
Uppsala SE

Orexo AB

Owner at Publication
03
Uppsala SE

Legal Representation

Attorney
Sarah J. Schneider

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Feb 3, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 3, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 27, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 24, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 28, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medical preparation for use as a narcotic antagonist in the treatment of narcotic overdose; Drug delivery devices, namely, nasal delivery devices sold filled with pharmaceutical preparations for use in the treatment of narcotic overdose; Pharmaceutical preparations in the form of powders for treatment of opioid addiction and overdose

Classification

International Classes
005